An International Perspective on Drugs for Cancer-Reference-Cited by-同舟云学术

An International Perspective on Drugs for Cancer

Author:

Lehman Richard¹,Gross Cary P.²³⁴

Affiliation:

1. Institute of Applied Health Research, College of Medical and Dental Sciences, Murray Learning Centre, University of Birmingham, United Kingdom

2. Department of General Medicine, Yale School of Medicine, New Haven, Connecticut

3. Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut

4. Cancer Outcomes Public Policy and Effectiveness Research (COPPER) Center, New Haven, Connecticut

Publisher

American Medical Association (AMA)

Subject

Internal Medicine

Link

Reference9 articles.

4. Assessment of the clinical benefit of cancer drugs receiving accelerated approval;Gyawali;JAMA Intern Med

5. An overview of cancer drugs approved by the US Food and Drug Administration based on the surrogate end point of response rate;Chen;JAMA Intern Med

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

3. Watch out for the endpoints in head & neck oncology!;European Annals of Otorhinolaryngology, Head and Neck Diseases;2020-12

4. Attention aux critères de jugement en cancérologie cervico-faciale !;Annales françaises d'Oto-rhino-laryngologie et de Pathologie Cervico-faciale;2020-12